Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5850_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
49 Мб
Скачать
Herbal Medicines fortheTreatment ofLiver Cirrhosis
https://t.me/medicina_free
187
a metabolic pathway that is complex and tightly regulated. DNL metabolizes additional carbohydrates into FFAs, which are then esteried into TGs [12]. FAS catalyses the nal step in fatty acid production [13]. Liver- specic fatty acid syn­thase (FAS) inhibition increased hepatocyte malonyl-CoA levels that block fatty acid beta-oxidation. ACC catalyses a major rate-limiting step in fatty acid biosynthesis and con­trols FAO by synthesizing malonyl-CoA [14]. Two important transcription factors for fatty acid synthesis, SREBP-1c, and ChREBP are engaged in lipid synthesis and have been linked to promoting DNL in NAFLD. SREBP-1c controls lipid metabolism transcriptionally [15]. The liver X receptor alpha (LXRα) is crucial in the upregulation of SREBP-1c and ChREBP [16].
The activity of adipokines, which are cytokines generated by adipocytes, such as leptin and tumour necrosis factor-α (TNF-α), which are produced in excess, also contributes to an increase in the oxidative stress that is placed on mitochon­dria [17]. It is more likely for inammatory adipokines to be active when there is a decrease in adiponectin that regulates other chemical mediators [18]. These chemical mediators, produced by inammatory response and cell death, activate the hepatic stellate cells (HSCs) and stimulate collagen lev­els, ultimately promoting brosis and cirrhosis [19].
3 Herbal Molecules Involved
intheManagement ofLiver Cirrhosis
3.1 Alkaloids
Alkaloids are organic compounds found in plants that are alkaline and contain nitrogen. Almost all alkaloids have cyclic structures and substantial impacts on lipid metabo­lism. Importantly, alkaloids act on AMPK, enhancing PPAR-α and carnitine palmitoyl transferase (CPT) 1 expres­sion while decreasing SREBP-1c and PPAR-γ. Because phy­tochemicals in this class promote lipid catabolic metabolism and inhibit anabolic lipid metabolism, the availability of lip­ids like fatty acids may be constrained [20]. In addition, some alkaloids with potent hepatoprotective action have been discussed below as shown in Fig.2.
3.1.1 Berberine
Berberine (BBR) is an isoquinoline alkaloid obtained from the stem of Berberis aristate [21]. Enhancement in insulin secretion and reversal of IR are the main functions of BBR.BBR has shown a decrease in liver lipid accumulation and prevention of hepatic steatosis, which simultaneously inhibits hepatic inammation and oxidative stress by hamper­ing lipogenesis [22]. Lipogenesis was lowered by the activat­ing transcription factor 6 (ATF6) and SREBP-1c pathways. SREBP-1c is a major target protein of BBR, which may have led to the prevention of lipid deposition and endoplasmic
reticulum (ER) stress-induced activation of SREBP-1c [23]. In another experiment, through the stimulation of the adenos­ine 5-monophosphate activated protein kinase (AMPK), SREBP-1c pathways, BBR decreased liver TG production and mitigated hepatic steatosis. The downregulation of Sirtuin 3 (SIRT3) expression might occur in rat liver [24]. The anti­inammatory effect of BBR was shown by downregulating the expression of inammation markers, like TNF-α and IL-6. In 3T3-L1 adipocytes, BBR lowered leptin and glycerol secretion [25]. This alkaloid decreases liver inammation in mice by reducing the phosphorylation state of c-Jun N-terminal protein kinase 1 (JNK1) and mRNA expression levels. BBR has been found to signicantly reduce inamma­tion in hepatocytes in a time and dose- dependent manner and diminished the expressions of FAS and ACC by BBR [26]. BBR has been shown to inhibit hypoxia-inducible factor (HIF-2α) storage, which lowered ceramide and ameliorated IR by HIF-2α genes. Through the PP2A-AKT-GSK3 signal­ling pathway, BBR improved IR by promoting glycogen pro­duction [27].
3.1.2 Caeine
Caffeine (CFN) is obtained from the roasted seeds of Coffea arabica and Coffea canephora. In individuals with NAFLD
and hepatitis C and B virus infection, drinking coffee loosens up the liver, which might lead to reduced brosis and inam­mation. Liver diseases have been found to occur less often in those who drink coffee. CFN has been shown to prevent liver brosis by inhibiting hepatic stellate cell activation by block­ing A2A receptors. New research suggests that CFN may also positively affect angiogenesis and hepatic hemodynam­ics. The expression of connective tissue growth factor pro­duced by transforming growth factor β (TGF-β) in hepatocytes is inhibited by CFN.CFN treatment in rats with chemically induced liver brosis has lowered their TGF-β levels. Hepatoprotective properties are shown by chloro­genic acid (an ester of CFN) that lowered tetrachlorobenzoquinone- induced oxidative stress and also decreased liver brosis and collagen I and III expressions; therefore, it must have a hepatoprotective character [28]. The metabolic actions of CFN that protected the liver were unclear. In hepatitis C virus-infected individuals, a higher CFN intake was linked to a lower level of liver brosis [29]. CFN and its metabolite paraxanthine reduced hepatic bro­sis by preventing the liver parenchyma from secreting con­nective tissue growth factor and also lowered iron buildup in the liver and ALT levels. Additionally, CFN reduced the pro­duction of alpha smooth muscle actin (α-SMA) in LX-2 cells and promoted stellate cell deactivation. Treatment with CFN resulted in a rise in apoptotic cells. The increased apoptosis rate was directly correlated to the length of exposure and the amount of CFN present. Cell migration and adhesion are all regulated by F-actin. In response to coffee administration, F-actin expression was signicantly lowered. Focal adhesion
188
O
Neferine
https://t.me/medicina_free
T. Banerjee et al.
O
O
O
Berberine
O
+
N
N
ON
Caffeine
N
N
Capsaicin
H N
O
OH
O
O
O
HO
OH
NH
O
HN
O
N
N
N
N
O
O
N
N
O
N H
O
O
Conophylline
Evodiamine
Ligustrazine
O
O
O
N
OH
O
N
O
Fig. 2 Alkaloids in the treatment of liver cirrhosis
complex and integrins trigger focal adhesion kinase (FAK), which is important for ECM growth factor stimulation and cell attachment and motility. CFN downregulated the HSCs expression of FAK.CFN modulated suppressor of mothers against decapentaplegic (SMAD)-induced production of ECM components to enhance intracellular cAMP concentra­tion [30].
3.1.3 Capsaicin
The primary ingredient in Genus Capsicum is capsaicin (CSC) [31]. In obese mice, CSC showed anti-steatotic action. Mice on a high-fat diet (HFD) had their liver fat decreased
-
O
+
N
N
O
Oxymatrine
when CSC was applied topically. CSC decreased the expres­sion of key enzymes involved in the synthesis of fatty acids, such as ACC and FAS, while increasing the expression of CPT1 and cluster of differentiation 36 (CD36), which are linked to oxidation and the inux of FFAs into the liver. Mice treated with CSC elevated adiponectin concentration in liver tissue. For the transient receptor potential vanilloid 1 (TRPV1) channel, CSC is a highly selective agonist, attenu­ating metabolic abnormalities by activating TRPV1, which stops the progression of fatty liver in vivo. In mice, dietary CSC, which activated TRPV1, enhanced PPAR-dependent autophagy and thus prevented NAFLD.Additionally, AMP-
Herbal Medicines fortheTreatment ofLiver Cirrhosis
https://t.me/medicina_free
189
activated protein kinase (AMPK), PPAR, uncoupling protein 1 (UCP1), and glucagon-like peptide 1 (GLP-1) were all altered by the liver tissue’s elevated expression of TRPV1. CSC reduced liver tissue inammation, which may have been brought on by AMPK signalling via the TRPV1 receptor being phosphorylated. As one of the modes of action of CSC, a systemic increase in adiponectin levels facilitates hepatic AMPK activation. Through the activation of AMPK, topical CSC treatment combined with exercise reduced the symp­toms of metabolic syndrome brought on by hypoestrogen­ism. CSC inhibited fatty liver by inhibiting lipogenesis and increased fatty acid oxidation by activating AMPK [32].
3.1.4 Conophylline
The vinca alkaloid conophylline (CNP) is taken from the leaves of the tropical plant Tabernaemontana divaricate. It improved hepatic brosis diseased mice condition and cured NASH also in mice. Additionally, the diet decreased the expression levels of hepatic PPAR-α mRNA.PPAR-α par­ticipates in β-oxidation. Hepatic PPAR-α and its target genes, such as CPT1 and CPT2, were upregulated in the liver by CNP in a dose-dependent manner. CNP elevated hepatic β-hydroxybutyrate level in a dose-dependent manner and decreased the expression of the p62 protein, which is reported to be preferentially destroyed during autophagy while enhancing the expression of the autophagosomal marker light chain 3 II (LC3-II). CNP reduced hepatic steatosis by elevating liver β-oxidation and autophagy [33].
3.1.5 Evodiamine
One of the main elements taken from Evodia rutaecarpa is evodiamine (EDM). ALT and histological abnormalities in liver tissues might all be improved by EDM.EDM decreased IL-6, TNF-α, collagen I, and collagen III.EDM decreased the protein expression of TGF-β1, phosphorylation of SMAD 2/3 (p-SMAD 2/3), and α-smooth muscle actin (α-SMA) in liver tissues as well as the mRNA expression of TGF-β1 and α-SMA.EDM dose-dependently lowered the cell prolifera­tion, hydroxyproline formation, and protein expression of TGF-β1, p-SMAD 2/3, and α-SMA in HSCs. EDM also reduced collagen metabolism and HSC proliferation [34].
3.1.6 Ligustrazine
Ligustrazine (LTZ) was discovered in the Chinese plant Ligusticum wallichii. It can block calcium channels, cause vasodilation, decrease platelet bioactivity and aggregation, scavenge oxygen free radicals, protect the liver, and have antibrosis properties. While lowering the expression of pro­teins linked to hepatic brosis and apoptosis, LTZ has also decreased the number of foci containing CD45-positive cells. Hepatic steatosis and hyperlipidaemia brought on by alcohol were also eliminated. LTZ enhanced the PPAR-α and CPT1 expressions, which decreased the number of lipid
droplets in the liver by inhibiting the gene and protein expres­sion of SREBP-1c and FAS.LTZ diminished the alcohol­mediated upregulation of SREBP-1c and downregulated the expression of PPAR-α, resulting in increased lipogenesis and reduced lipolysis. Furthermore, LTZ has shown antioxidant activity by increasing the production of glutathione, SOD, and catalase which may have been lowered by alcohol. These results support the potency of LTZ against liver cirrhosis [35].
3.1.7 Neferine
Nelumbo nucifera seed embryo is the source of neferine (NFR). It has anti-oxidative, anti-inammatory, and anti­pulmonary brosis properties. Collagen’s primary building block, hydroxyproline, forms the extracellular matrix (ECM). At the level of liver cirrhosis, ECM deposition might permanently worsen the function of the liver. NFR promoted apoptosis of cultured hepatic stellate cells (HSCs) by reduc­ing their stimulation. The mediator causing chronic liver dis­ease through inammation, and brogenesis, is TGF-β1. To form the ECM, TGF-β1 can induce HSCs to produce and secrete collagen and bronectin. Plasma levels of ALT and AST were dramatically reduced by NFR.Thus, NFR exhib­ited an antibrosis impact on the hepatic brosis brought on by CCl4 in vivo [36].
3.1.8 Oxymatrine
Sophora avescens contains signicant amounts of oxyma­trine (OXM). OXM lessened fat accumulation by regulating the expression of miR-182. The ratio of liver to body weight, the amount of TG, hepatic lipid buildup, and steatosis were all decreased by OXM.Following OXM intervention, the levels of SREBP-1c, ACC, and fatty acid synthase (FAS) were all dramatically reduced, while the level of CPT1A was increased in the high-fat diet (HFD)-fed rat in the experi­ment. In the same experiment in miR-182 knockdown rats, SREBP-1c, ACC, and FAS levels were all elevated, but the CPT1A level was decreased [37]. SOD, glutathione peroxi­dase (GPx), and choline acetyl-transferase (CAT) activity reduced in response to As2O3, and the decline was prevented by treatment with OXM.OXM also enhanced the expression of Nrf2 and heme oxygenase-1 (HO-1) while reducing the retention of arsenic in liver tissues. Through the Nrf2/HO-1 signalling pathway, OXM has shown protection against oxi­dative damage carried out by As2O3 [38]. PPAR-α, CPT1A, and microsomal TG transfer protein (MTTP) mRNA and protein levels were all signicantly raised by OXM therapy. The nding of a reduction in lipid buildup in the liver served as an additional conrmation of OXM-positive effects [39]. Apart from the above discussed herbal com­pounds,(Table 1) enlists several phytochemicals involved in the treatment of various liver ailments by targeting lipid biomarkers.
190
https://t.me/medicina_free
T. Banerjee et al.
[40]
Downregulated α-SMA, COL1A1, and TGF-β1 protein
expressions and TIMP-1, TIMP-2, and MMP-2 mRNA
expressions
[41]
[42]
Upregulated the expression of PPAR-α
Downregulated TGFβ1-induced hepatocyte EMT and HSC
[43]
[44]
Upregulated Nrf2 signalling
Decreased serum AST level and inhibitedthe release of TNF-α
Activated AMPK signalling pathway decreased glucose output,
cholesterol, and TG synthesis
[46]
the expression of α-SMA and HSCs
[49]
production of IL-6, IL-1β, IFN-γ, and TNF-α
Compound name Biological source Research model Biomarkers Refs.
Betaine Vegetables like beets, spinach, etc In vivo female Sprague-Dawley rats
Table 1 Names, biological sources, experiment research models, targeted biomarkers of alkaloids
HepG2 cells in vitro Lowered both TG and low-density lipoprotein metabolism
human LX-2 HSCs
In vitro TGF-β1/SMAD cascade
In vivo male Wistar albino rats
Nuciferine Nelumbo nucifera leaf In vivo male C57BL/6J mice
Piperine Black pepper (Piper nigrum) In vivo AML-12 hepatocytes and
Trigonelline Cantaloupe, corn, onions, peas,
rats
soybeans
Sophocarpine Foxtail-like sophora herb and seed In vivo male Sprague-Dawley (SD)
In vivo male C57BL/6 mice Reduced lipid accumulation and TG [45]
In vitro AML12 cells Activated AMPK/ACC
owers, leaves, and seeds
Liensinine Nelumbo nucifera, such as its root,
Theacrine Camellia assamica In vivo male Sprague-Dawley rats Activated SIRT3/AMPK and inhibited SCD1 signals. Reduced
In vitro HepG2 cells
Kukoamine A The root barks of Lycium chinense In vivo C57 mice Increased SREBP-1c protein, decreased FAS, and ACC [47]
Tiliamosine Tiliacora racemosa In vivo male Wistar rats Reduced TG [48]
Koumine Gelsemium elegans In vivo male Sprague-Dawley rats Lowered TG, TC, LDL, ALT, AST, and MDA reduced the
Herbal Medicines fortheTreatment ofLiver Cirrhosis
https://t.me/medicina_free
Fig. 3 Flavonoids in the treatment of liver cirrhosis
3.2 Flavonoids
191
both SMR and its metabolites have lowered IR and hyper­lipidaemia [52].
Fruits, vegetables, cereals, bark, roots, stems, owers, tea, and wine are all good sources of avonoids, a class of natural compounds with varying phenolic structures (Fig.3). It is hoped that isolating these natural compounds would yield their health benets. Therefore, avonoids are now widely recognized as an essential component in a wide range of nutraceutical, pharmacological, medical, and cosmetic prod­ucts [50].This section explores the pathological role of a­vonoids (Table 2) in management of cirrhosis and other liver ailments.
3.2.1 Naringenin
Naringenin (NGN) is a avonoid with anti-inammatory, anti-brogenic, antioxidant, and anticancer effects. NGN has shown protective effects in liver illnesses by inhibiting oxi­dative stress through the TGF pathway and preventing the transdifferentiation of HSCs, which decreases collagen for­mation. Non-canonical pathways for the toll-like receptor (TLR), TGF-β, and mitogen-activated protein kinase (MAPK), which, when inhibited, further caused a signicant decrease in extracellular matrix (ECM) synthesis and depo­sition. Through regulating lipid metabolism, NGN has dem­onstrated a positive effect on NAFLD and inuenced the production and oxidation of lipids and cholesterol [51].
3.2.3 Baicalin
Baicalin (BAI) is a monomeric avonoid mainly obtained from Scutellaria baicalensis Georgi. This active phytochem- ical is used in the composition of herbal medicine for the treatment of liver disease. BAI had anti-oxidative, anti­inammatory, and hepatoprotective activity against different types of liver injury caused by carbon tetrachloride, iron overload, and acetaminophen [53]. BAI protects the liver through its antioxidant effect by suppressing the production of reactive oxygen species, which help to protect against liver cirrhosis in ischemia/reperfusion injury in fatty liver disease. BAI reduced hepatic damage by suppressing the TLR4-mediated inammatory signalling pathway, providing protection against post-ischemic injury in the alcoholic fatty liver [54]. BAI boosted the activity of antioxidant response kinases like SOD and GSH-PX while decreasing the yield of inammatory factors, including TNF-α, IL-1β, and IL-6. BAI also lowered the regulations of the extracellular signal­regulated kinase (ERK), one of the primary targets. BAI also downregulates SOD and GSH-Px activity to reduce oxida­tive stress leading to a decrease in hepatic brosis. By con­trolling the activity of SREBP-1c, FAS, PPAR-γ, and CPT1, BAI can partially decrease the hepato-lipids accumulation triggered by an MCD diet [55].
3.2.2 Silymarin
Silymarin (SMR) is the name for the avonolignans identi­ed in milk thistle (Silybum marianum). The levels of ALT and AST were somewhat decreased by SMR.In addition,
3.2.4 Quercetin
Quercetin (QRC), a plant pigment and more precisely a a­vonol, is primarily present in citrus fruits, berries, and grapes. It is an antioxidant that could prevent cellular damage caused
192
https://t.me/medicina_free
Table 2 Names, biological sources, experiment research models, targeted biomarkers of avonoids
Compound name Biological source Research model Biomarkers Refs. Nobiletin Citrus sinensis and Citrus
limon
Dihydromyricetin Ampelopsis grossedentata In vivo mice
Rutin Fruits, tea, and wine, Ruta
graveolens
Luteolin Dendranthema morifolium In vivo Wistar rats
Scutellarin Erigeron breviscapus In vivo male C57BL/6
Genistein Soybean products
(Cordyceps sinensis)
Fisetin Fruits and vegetables In vivo male albino rats
Quercetin3-O-β-D­glucuronide
Quercitrin Fruits and vegetables In vivo female
Vitexin Ficus deltoidei and
Chrysin Passiora caerulea and
Galangin Rhizome of Alpinia
Hesperetin Citrus fruits (oranges,
Hesperidin Citrus genus In vivo HFD-fed rats
Bavachinin Fructus Psoraleae In vitro HepaRG cells Inhibited FDFT1 via the AKT/mTOR/SREBP-2
Didymin Mentha spicata In vivo HFD-fed mice
Ugonin J Helminthostachys
Hyperoside Hawthorn, artemisia
Icariin Epimedium genus In vivo male C57BL/6J
Xanthohumol Humulus lupulus, beer In vivo male Wistar rats Decreased GPx and GST; increased TBARS [77] Breviscapine Erigeron breviscapus In vivo male C57BL/6J
Myricetin Berries, vegetables, and
Polygonum perfoliatum In vivo male SD rats; in
hawthorn
Oroxylum indicum
galangal
grapefruit, and lemons)
zeylanica
capillaris, and Hypericum perforatum
herbs
In vivo male C57BL/6J mice
In vivo male C57BL/6 mice
mice
In vivo male Wistar rats Downregulated JAK2/STAT3/SOCS3 signalling
vitro Q3GA gene
C57BL/6 mice In vivo male C57BL/6J
mice In vivo Wistar rats Upregulated RAS, ACE2, Ang (1–7), and Mas [68]
In vivo male Wistar rats; in vitro BRL cell
In vivo male Wistar rats; in vitro HepG2 cells
In vitro THP1 and HepG2 cells
In vivo male C57BL/6J mice; in vitro, PA-induced steatotic human HuS-E/2
In vivo Wistar male rats Altered DNL, ApoE, and BSEP; increased NRs, FXR,
mice
mice
In vivo male BALB/c mice
Lowered HDL-C/TC ratio. Downregulation of SREBP-2 and ACAT2
Decreased CRP, IL-6, and IL-1β Decreased ALT, AST, γ-glutamyl transpeptidase,
LDL-C, TNF-α, and broblast growth factor 21 blocked the PI3K/Akt/NF-κB signalling pathway
Downregulated PPAR-α, CPT1, and CPT2 suppressed SREBP-1c, DGAT-1 and 2, ACC, TNF-α, and IL-1β. Reduced TG
Inhibited NF-κB and TLR4 signalling pathway
Suppressed IRE1α/XBP1 pathway Downregulated SREBP-1c, FAS, and ACC Upregulated Beclin1 and Foxo1 proteins
pathway Downregulated genes MMP2/9 and TIMP1 Upregulated SOCS3 protein and CD163 and CD206
inhibited CD68 Upregulated HNF4α/lipin1 signalling Inhibited ROS mediated TXNIP induction Upregulated PPAR-α, MCAD, and CPT1
Downregulated FFA and SREBP-1c Reduced TG, TC, LDL-C; Downregulated TNF-α, IL-6,
and IL-1β Increased PPAR-γ protein; activated AMPK
Decreased ALT/AST; mediated caspase 3; inhibited BRL cell apoptosis and PI3K/AKT pathway
Upregulated SOD/GPx/HO-1; triggered the PI3K/ AKT-Nrf2 pathway; reduced ROS accumulation and TG, TC, LDL-C levels
Suppressed GRP94, ATF6, PERK, IRE1α, IL-1β, IL-6, and TNF-α; activated IRE1α
pathway and cholesterol synthesis Suppressed the TLR4/NF-κB and PI3K/Akt pathways;
decreased ALT, AST; reduced the expressions of ACC, SREBP-1c, LXRα, and FAS
Upregulated pAMPK, ACC, and CPT1; downregulated SREBP-1c
LXRα
Upregulated of the cleaved caspase 3/9, SREBP1c, and DGAT2; enhanced CPT1, ACC, AMPKα1, PGC1α, and GLUT4; activated AMPKα1/PGC1α/GLTU4 pathway
Inhibited TGF-β-activated kinase 1 (TAK1) phosphorylation; inhibited NF-κB signalling pathway; downregulated Col1a1, Col3a1, Ctgf, and Timp1 genes; downstream JNK/p38 activation
Blocked phosphorylation of SMAD2/Akt/MAPK; inhibited PDGF and TGF-β1; activated JNK phosphorylation
T. Banerjee et al.
[57]
[58]
[59]
[60,
61]
[62]
[63]
[64]
[65]
[66]
[67]
[69]
[70]
[71]
[72]
[73]
[74]
[75]
[76]
[78]
[79]
Herbal Medicines fortheTreatment ofLiver Cirrhosis
https://t.me/medicina_free
193
by the toxicities of different drugs. Through several path­ways, including nuclear factor kappa B (NF-κB), p53, and phosphoinositide-3-kinase-protein kinase B/Akt (PI3K/Akt) downregulation, QRC has been demonstrated to inhibit apoptosis in normal cells. The anti-inammatory mecha­nisms of QRC also demonstrate that it inhibits many pro­inammatory mediators and enzymes implicated in the processes of hepatotoxicity, including TNF-α, IL-1β, IL-6, cyclooxygenase-2 (COX-2), and nitric oxide synthase (iNOS) [56].
3.3 Polyphenols
Polyphenols are bioactive compound that play an important role in the survival of the plant against harmful environmen­tal factors including UV light and infections. Dietary plant polyphenols have gained a lot of attention in the past decade due to the possibility that they may improve health by acting as antioxidants. Polyphenols may be found in a wide variety of whole foods, including vegetables, fruits, grains, and even certain drinks. For instance, the fresh weight of 100 grams of grapes, apples, pears, cherries, and berries might contain anywhere from 200 to 300mg of polyphenols [80]. Bioactive polyphenols in the management of liver cirrhosis have been discussed, summarized (Table 3) and illustrated below in Fig.4.
3.3.1 Catechin
Camellia sinensis is high in polyphenolic catechin (CAT), which directly shields progression of NAFLD.Consuming green tea is linked to decreased levels of aminotransferases, TGs, and atherogenic lipoproteins in the bloodstream, as well as a reduced risk of cardiovascular disease and all-cause mortality closely related to NAFLD as determined by human clinical studies. Green tea CATs may prevent steatosis by inhibiting intestinal lipid and carbohydrate absorption, reducing adipose lipolysis and both adipose and hepatic DNL, stimulating hepatic β-oxidation and thermogenesis, and the improvement of insulin sensitivity [81]. While rais­ing the quantity of the antioxidant enzyme SOD, GTP low­ered inammation by lowering levels of IL-6 and TNF-α, as well as the histological signs of liver damage. The modica­tion of AMPK activity, as GTP-enhanced AMPK phosphory­lation, may be the suggested mechanism [82].
3.3.2 Resveratrol
A naturally occurring polyphenolic substance called resvera­trol (RSV) may be found in jackfruit, peanuts, and grapes. In vivo RSV-mediated changes to the gut microbiota, associ­ated gut metabolites, and intestinal environment redox status helped protect C57BL/6J male mice from developing meta­bolic syndrome when they were given an HFD.Two RSV
gut metabolites, 4-hydroxyphenyl acetic acid and 3- hydroxyphenylpropionic acid, have demonstrated enhanced lipid metabolism in vitro [83]. This polyphenol stopped the downregulation of SREBP-1c and FAS brought on by steatosis and its effect on phosphorylated AMPK.After RSV administration, plasma ALT levels were dramatically reduced [84].
3.3.3 Curcumin
Curcumin (CUR) is primarilyderived from Curcuma longa. CUR liposomes improved pharmacological and anticancer effects [85]. CUR imparted signicant reduction ofhepatic fat levels inNAFLD patientsby reducing the serum lipo­genic markers. The glycemic and lipid proles, transaminase levels, and anthropometric measurements were also exam­ined. The effectiveness of CUR in preventing liver outcomes like cirrhosis and hepatocellular cancer, as well as its anti­steatotic activities, is dose-dependent. Following treatment with CUR, signicant reductions in FBS and HbA1c levels were noted [86].
3.3.4 Chlorogenic Acid
The most prevalent antioxidant in coffee (Coffea arabica) is chlorogenic acid (CGA), though other plants also produce it. Coffee has anti-inammatory and antioxidant properties that help ght cancer, cirrhosis, and liver brosis. CFN treatment decreased lipogenesis and boosted lipid beta-oxidation in HFD rats. The PPAR-α pathway is inactivated, which has an anti-inammatory and antioxidant impact in addition to reduced fat storage [87]. The control of glucose and lipid metabolism and associated diseases, including diabetes, car­diovascular disease, obesity, cancer, and hepatic steatosis, is thought to be impacted signicantly by CGA [88].
3.3.5 Anthocyanin
In peripheral blood mononuclear cells, anthocyanin (ACY) supplementation signicantly reduced plasma levels of IL-1β and IL-18in NAFLD patients relative to controls and mRNA expression of NLRP3 inammasome components (caspase­ 1, IL-1β, and IL-18). NAFLD pathophysiology is related to the activation of NLRP3 inammasomes [89]. ACY reduced hepatic lipid buildup and mitigated oxidative stress and hepatic inammation. Reduced lipogenesis and increased lipolysis caused by increased PPAR-𝛼 activity were pro­posed as the causes of the lower hepatic fat content. One research found enhanced AMPK pathway activity, and sev­eral studies using experimental models of NAFLD found improved hepatic antioxidant activity following exposure to ACY [90].
3.3.6 Mangiferin
A typical aqueous stem bark extract from Mangifera indica exhibits strong in vitro and in vivo antioxidant activity.
194
https://t.me/medicina_free
T. Banerjee et al.
[93]
of PXR and AHR, IL-1β, IL-2, CD4+ T cell expansion,
neutrophil proliferation, and cell division; suppressed
immune cells and sIgA
[94, 95]
Attenuated M1 macrophages and increased M2
macrophages after LPS stimulation; descended cytokine
[96, 97]
(TNF-α, IL-1β, IL-6, IL-10, IL-4) level; suppressed ERK
pathway in macrophages
CHOP; increased activity of enzymic and non-enzymic
antioxidants; alleviated lipogenesis via the AMPK
pathway
[98]
Reduced hepatic levels of ROS, MDA, TNF-α, and IL-6
and the nuclear activity of NF-κB, p65; increased Nrf2 and
GSH and SOD; downregulated SREBP1, SREBP2, ACC,
[99]
FAS, and HMG-CoAR stimulated PPAR-α and CPT1A,
CPT1A, and AMPK
Activated PI3K/AKT pathway; reduced NO and ROS via
Nrf2 signalling pathways; inhibited SREBP-1c and
PNPLA3, and upregulated PPAR-α
[100]
[101]
decreased P-JNK, P-ERK, and P-P38
Improved A CC and FAS genes; increased PPAR-α and
CPT1 expression; decreased FAS and HMG-CoA
[102]
reductase expression
SREBP-1c, C/EBP1α, and FAS IL-1β, TNF-α, and
[103]
COX-2a decreased; upregulated phosphorylation of
AMPK and SIRT1
Reduced ROS formation; reduced the growth of breast and
prostate cancers
[104]
Reduced ECM production, HMGB1 release, hyaluronic
acid, and collagen IV; promoted mitochondrial biogenesis;
[105]
[106, 107]
decreased α-SMA, SMAD2/3, COL1A1 and COL3A1,
TG, and NEFA
ɑ-SMA and TGF-β1
Upregulated microRNA-467b-3p, HNF4ɑ; decrease in
glycerol-3-phosphate acyl-transferase-1; Downregulated
GPAT1
[108]
Promoted PPAR-ɑ, CPT1, and ACOX1; activated AMPK
phosphorylation; dampened TNF-α, IL-6, IL-8, and IL-1β
secretion, and NF-κB expression
Compound name Biological source Research model Biomarkers Refs.
Epigallocatechin-3-gallate Green tea (Camellia sinensis) In vivo HFD-fed mice Downregulated CYP450 enzymes inhibited the expression
Table 3 Names, biological sources, experiment research models, targeted biomarkers of polyphenols
in vitro RAW 264.7 cells
Hydroxytyrosol Virgin olive oil (Olea europaea) In vivo male C57BL/6 mice;
Rosmarinic acid Rosmarinus ofcinalis In vitro HepG2 cells Reduced ROS and p-PERK, p-IRE-1, ATF-6, p-eIF-a, and
In vivo male Wistar rats
strawberries, pomegranates, guava,
etc.
Ellagic acid Various fruits, including
L02 and HepG2 cell
Dihydrocurcumin Turmeric (Curcuma longa) In vitro human liver cell line
In vivo male SWISS mice
berries, pequi (Caryocar
brasiliense), and wine; Phyllanthus
Chicoric acid Cichorium intybus In vivo male C57BL/6 mice Decreased AST and ALT; activated AMPK/Nrf2 pathway;
Gallic acid Fruits and vegetables teas, grapes,
transgenic Zebrash
emblica
Diphlorethohydroxycarmalol Ishigeo kamurae In vitro HepG2 cells; in vivo
rats
In vivo male C57BL/6 mice;
in vitro LX2 cells
pears, berries, artichokes, and
eggplant
CAT Camellia sinensis In vivo male Sprague-Dawley
CGA Coffee (Coffea arabica), apples,
Salvianolic acid A Salvia miltiorrhiza In vivo Sprague-Dawley rats Reduced TG, TC, LDL, ALT, and AST; Downregulated
C57BL/6Jmice
In vivo male C57BL/6 mice;
6-Gingerol Zingiber ofcinale In vivo HFD male
Methyl brevifolincarboxylate Phyllanthus urinaria, Canarium
in vitro human SK-HEP-1 cell
album
Herbal Medicines fortheTreatment ofLiver Cirrhosis
https://t.me/medicina_free
Fig. 4 Polyphenols in the treatment of liver cirrhosis
Mangiferin (MFR) is the primary polyphenolic component of Vimang. Polyphenols have a dual synergistic effect, making them potentially effective antioxidants against pathological iron overload diseases such as thalassemia, Friedreich’s ataxia, and hemochromatosis. The redox cycling of the metal and the ligand, notably MFR, the pri­mary catecholic polyphenol in the natural extract, might be used to explain the improved free radical scavenging capacity of Vimang following iron coordination. The sec­ond primary polyphenol of Vimang, MFR, is a catechol­containing molecule that likewise has signicant antioxidant activity; it has been shown that iron increases its superoxide scavenging capacity [91]. Furthermore, MFR pretreatment has been demonstrated to have a strong hepatoprotective impact by reducing blood levels of the inammatory mediator TNF-α, AST, ALT, alkaline phos­phatase, and bilirubin. In addition, MFR prevented the reduction of glutathione reductase, glutathione-S­transferase, SOD, and total reduced glutathione activity and increased hepatic MDA formation in the liver of CCl4­injected male Swiss albino mice [92].
3.4 Glycosides
In glycosides, a sugar moiety is attached to an aglycone structure (Fig. 5) through an O-, S-, N-, or C-glycosidic bond, making for yet another unique family of secondary metabolites. The glycosidic residue is crucial for bioactivity in several compounds. Hydrolysis of the glycosides, how­ever, produces an active aglycone or a cytotoxic defence chemical like hydrogen cyanide [109].
195
3.4.1 Glycyrrhizin
Glycyrrhizin (GLZ) is a naturally occurring glycoside iso­lated from the roots of the Glycyrrhiza uralensis. GLZ fre­quently employs as a avouring and sweetening factor in sweets, drinks, chewing gum, and tobacco products. It is also recognized for its pleasant fragrant sweet taste. GLZ helps to protect animals from multiple types of experimental liver damage. This active phytochemical had anti-inammatory, antioxidant, antimicrobial, and antiviral properties. GLZ suppressed TNF-α and CD4+ T cell-mediated cytotoxicity [110]. The deposit of bile acids caused by cholestatic hepatic injury in the liver and bloodstream typically causes severe hepatic inammation and helps in the progression of brosis and cirrhosis. GLZ stimulated the activity of the pregnane X receptor (PXR) in hepatic cells leading to downregulate the cholesterol 7-alpha-monooxygenase (CYP7A1) enzyme, an essential enzyme in the production of bile acids. GLZ sig­nicantly reduced ANIT-induced acute cholangiocyte and protected the liver against cholestasis by increased ANIT clearance and decreased inammation [111]. As a powerful antioxidant, GLZ signicantly reduced caspase-3 and cas­pase- 9 action and inhibited hepatocyte necrosis, inamma­tion, and brosis [112]. GLZ markedly reduced the production of both pro-inammatory mediators, such as TNF-α, iNOS, and COX-2 [113].
3.4.2 Paeoniorin
The primary active constituent, paeoniorin (PAE), was found in the roots of Paeonia lactiora Pall and Paeonia veitchii Lynch. It is a monoterpenoid glycoside molecule. Recent ethnopharmacological studies demonstrate the
196
HO
OOH
HO
Swertiamarin
OH
https://t.me/medicina_free
HO
O
OHOOH
O
OH
O
OO
Glycyrrhizin
OH
OH
T. Banerjee et al.
O
HO
HO
HO
OH
O
Paeoniflorin
O
O
O
OH
O
O
HO
O
O
O
O
HO
HO
HO
O
OH
OH
Vicenin-2
O
OO
O
O
Geniposide
OH
OH
O
O
O
O
OO
O
OH
O
OH
OH
HO
OH
HO
Salidroside
OH
OH
OO
OH
HO
HO
Schaftoside
O
HO
HO
OH
OH
OO
O
HO
O
OH
OH
OO
OH
OH
O
OH O
O
Fig. 5 Glycosides in the treatment of liver cirrhosis
hepatoprotective activity of PAE. A mechanistic study investigating the metabolic effects of PAE revealed that it primarily modulated phenylalanine, tryptophan, and tyro­sine biosynthesis, linoleic acid metabolism, inositol phos­phate metabolism, glycosylphosphatidylinositol-anchor biosynthesis, and primary bile acid biosynthesis, which may be responsible for its protective action in cholestatic liver injury [114]. PAE signicantly reduces serum bio­chemical markers and prevents hepatic tissue injury, indi­cating that it might have effectiveness against NIT-induced cholestasis [115]. PAE reduces PPAR-γ mRNA levels. It
lowers cholesterol by downregulating PPAR-γ-LXRα- ABCA-1 pathway. As a potential herbal medication, PAE has anti-NAFLD activity. Its NAFLD preventive impact was mediated by various pathways, including the de novo pathway, the lipid oxidation metabolism pathway, and the cholesterol synthesis and output pathway [116]. HIF-1α might induce liver brosis partially via mTOR. PAE administration potentially diminished the mTOR phos­phorylation and HIF-1α expression, and thus it inhibits brogenesis. PAE also downregulates the COL III and α-SMA genes responsible for the brosis of rats [117].